Lonza | LONN - Ebitda


Lonza reported CHF1.01B in EBITDA for its fiscal semester ending in December of 2025.





Ebitda Change Date
Akzo Nobel EUR 345M 540M Mar/2026
Alcon AG USD 795M 478M Mar/2026
Almirall EUR 114.07M 60.37M Dec/2025
AstraZeneca USD 5.67B 1.29B Mar/2026
BASF EUR 2.36B 217M Mar/2026
Bayer EUR 4.45B 2.49B Mar/2026
Beiersdorf EUR 984M 147M Jun/2025
Covestro EUR 117M 125M Dec/2025
Demant DKK 2.76B 165M Dec/2025
Fresenius EUR 951M 283M Mar/2026
Fresenius Medical Care EUR 824M 250M Mar/2026
Geberit CHF 177.6M 58.4M Dec/2025
Genmab DKK 186M 291M Dec/2025
Givaudan CHF 778M 195M Dec/2025
GlaxoSmithKline GBP 2.77B 1.65B Mar/2026
GN Store Nord DKK 491M 136M Mar/2026
Hikma Pharmaceutical USD 369M 84M Dec/2024
Johnson Matthey GBP 325M 52M Jun/2024
Merck EUR 1.53B 87M Mar/2026
Novartis USD 5.3B 530M Mar/2026
Philips EUR 567M 233M Mar/2026
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 3.31B 3.65B Mar/2026
Sika AG CHF 994.3M 76.1M Dec/2025
Smith & Nephew USD 796M 139M Dec/2025
Solvay EUR 219M 50M Mar/2026
UCB EUR 1.6B 570M Dec/2025